Does estrogen therapy reduce coronary artery calcification in postmenopausal women? Commentary

Nature Clinical Practice Cardiovascular Medicine

Volumn 4, Issue 12, 2007, Pages 654-655

  Stevenson, John C ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; PLACEBO;

ARTERY CALCIFICATION; ATHEROMA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; LONG TERM CARE; MORTALITY; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SHORT SURVEY;

EID: 36448975223     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1011     Document Type: Short Survey

References (5)

1. Stampfer MJ and Grodstein F (1994) Role of hormone replacement in cardiovascular disease. In Treatment of the Postmenopausal woman. Basic and Clinical Aspects, 223-233 (Ed. Lobo RA) New York: Raven Press
2. Stevenson JC (2005) Menopausal hormone therapy. In Women and Heart Disease, edn 2 375-390 (Eds Wenger NK and Collins P) London: Taylor & Francis
3. Hulley S et al. (1998) Randomized trial of estrogen plus progestin for secondary preventon of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280:605-613
4. Rossouw J E et al. (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297: 1465-1477
5. Mikkola TS and Clarkson TB (2002) Estrogen replacement therapy, Atherosclerosis, and vascular function. Cardiovasc Res 53: 605-619